G. Tsurita

Molecular Biology · 2016–2017

A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 41 citations into it

Whom G. Tsurita trusts

Their strongest outbound trust, strongest first, inferred from their citations.

1. Ryuji Hamamoto (in Molecular Biology)
2. Yusuke Nakamura (in Molecular Biology)

Papers from G. Tsurita's perspective

Ordered by how strongly the researchers G. Tsurita trusts endorse each paper. Same corpus, a different order for every researcher.

1. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
2. Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers
3. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
4. ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors (Nature Reviews. Cancer)
5. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3 (Nature Reviews. Cancer)
6. Critical role of lysine 134 methylation on histone H2AX for γ-H2AX production and DNA repair
7. PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP
8. Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
9. A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5′ flanking region of SMYD3 is a risk factor for human cancers
10. Validation of the histone methyltransferase EZH2 as a therapeutic target for various types of human cancer and as a prognostic marker

Their papers

• Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization (2017) — 31 citations
• SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1 (2016) — 51 citations